WAVE Life Sciences Ltd. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
152.00
1,485.00
3,704.00
14,414
Cost of Goods Sold (COGS) incl. D&A
276.00
281.00
-
-
-
-
Gross Income
276.00
281.00
-
-
-
-
SG&A Expense
3,298.00
5,113.00
18,856.00
56,028.00
104,129.00
168,356
EBIT
3,574.00
5,394.00
19,298.00
55,327.00
102,580.00
159,523
Non Operating Income/Expense
37.00
261.00
56.00
205.00
1,247.00
12,917
Interest Expense
111.00
12.00
-
-
-
-
Pretax Income
3,648.00
5,145.00
19,156.00
54,785.00
101,327.00
146,584
Income Tax
330.00
84.00
44.00
616.00
708.00
69
Consolidated Net Income
3,318.00
5,229.00
19,200.00
55,401.00
102,035.00
146,653
Net Income
3,318.00
5,229.00
19,200.00
55,401.00
102,035.00
146,653
Net Income After Extraordinaries
3,318.00
5,229.00
19,200.00
55,401.00
102,035.00
146,653
Net Income Available to Common
3,318.00
5,229.00
19,200.00
55,401.00
102,035.00
146,653
EPS (Basic)
1.90
1.34
1.83
2.43
3.85
5.06
Basic Shares Outstanding
20,308.30
20,308.30
10,501.50
22,800.60
26,513.40
28,970.40
EPS (Diluted)
0.16
0.26
1.83
2.43
3.85
5.06
Diluted Shares Outstanding
20,308.30
20,308.30
10,501.50
22,800.60
26,513.40
28,970.40
EBITDA
3,298.00
5,113.00
18,704.00
54,543.00
100,425.00
153,942
Non-Operating Interest Income
-
-
86.00
337.00
6.00
-
About WAVE Life Sciences
View Profile
